Detection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing data.
暂无分享,去创建一个
Ahmet Zehir | Donavan T. Cheng | Aijazuddin Syed | Maria E Arcila | Donavan T Cheng | Michael F Berger | M. Berger | M. Arcila | K. Nafa | R. Levine | A. Zehir | Aijazuddin Syed | C. Hedvat | Janice Cheng | Talia Mitchell | Alifya Oultache | Ross L Levine | Cyrus V Hedvat | Janice Cheng | Talia N Mitchell | Nana Yaa T Mensah | Alifya Oultache | Khedoudja Nafa | Nana Mensah
[1] Carl W. Miller,et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. , 2002, Blood.
[2] John D Pfeifer,et al. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data. , 2013, The Journal of molecular diagnostics : JMD.
[3] A. Kohlmann,et al. Landscape of TET2 mutations in acute myeloid leukemia , 2012, Leukemia.
[4] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[5] S A Forbes,et al. The Catalogue of Somatic Mutations in Cancer (COSMIC) , 2008, Current protocols in human genetics.
[6] M. Cazzola. IDH1 and IDH2 mutations in myeloid neoplasms – Novel paradigms and clinical implications , 2010, Haematologica.
[7] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[8] Rashmi Kanagal-Shamanna,et al. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics , 2014, Modern Pathology.
[9] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[10] D. Gary Gilliland,et al. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders , 2007, Nature Reviews Cancer.
[11] Axel Benner,et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. , 2008, The New England journal of medicine.
[12] Nikhil Wagle,et al. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. , 2012, Cancer discovery.
[13] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[14] S. Raimondi,et al. Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. , 2009, Blood.
[15] Brunangelo Falini,et al. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. , 2007, Blood.
[16] Fabien Campagne,et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. , 2010, Cancer cell.
[17] T. Naoe,et al. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. , 2001, Blood.
[18] S. Raimondi,et al. Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. , 2010, Blood.
[19] Torsten Haferlach,et al. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] B. Löwenberg,et al. A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects. , 2009, Blood.
[21] Rashmi Kanagal-Shamanna,et al. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. , 2013, The Journal of molecular diagnostics : JMD.
[22] T. Naoe,et al. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines , 1997, Leukemia.
[23] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[24] W. Grody,et al. Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. , 2008, The Journal of molecular diagnostics : JMD.
[25] M. Sanders,et al. The evolving molecular genetic landscape in acute myeloid leukaemia. , 2013, Current opinion in hematology.
[26] Ken Chen,et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.
[27] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[28] Doron Lipson,et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies , 2012, Nature Medicine.
[29] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[30] J. Reis-Filho,et al. Next-generation sequencing applied to molecular diagnostics , 2011, Expert review of molecular diagnostics.
[31] Chieh-Yu Liu,et al. WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system. , 2010, Blood.
[32] D. Gilliland,et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. , 2006, Blood.
[33] Pu Zhang,et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia , 2001, Nature Genetics.
[34] Shuying Sun,et al. Global mutational profiling of formalin-fixed human colon cancers from a pathology archive , 2012, Modern Pathology.
[35] Ken Chen,et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples , 2009, Bioinform..
[36] Olivier Harismendy,et al. Microdroplet-based Pcr enrichment for large-scale targeted sequencing , 2016 .
[37] Sandra A. Moore,et al. MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia , 2006, PLoS medicine.